STAT News, March 2026 254M Indians with generalised obesity ICMR-INDIAB 17 43.3% Metabolically obese at normal BMI ICMR-INDIAB 23 BMI 23 WHO Asia-Pacific overweight threshold for South Asians WHO Asia Pacific Guidelines CLINICAL TRANSPARENCY GLP-1 therapy is clinically proven and well-tolerated by most patients
However, their stability was hampered by a number of factors, including serum proteins
Intranasal dexmedetomidine for sedation in children undergoing transthoracic echocardiography studya prospective observational study
2 monthly B12 shots , elevating your vitality
Weight loss improves glucose, lipids, blood pressure, and obesity-related comorbidities, and clinicians can offer multiple effective obesity treatments
You may need to provide current medications and supplements, known allergies and adverse reactions, existing medical conditions, previous surgeries or hospitalisations, family medical history (where relevant), current symptoms or health concerns, height and weight (for BMI calculation), and blood pressure readings (where required)
